| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2003 | WO2003011810A1 Method for the nitration of phenolic compounds |
| 02/13/2003 | WO2003011808A1 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 02/13/2003 | WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | WO2003011396A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 02/13/2003 | WO2003011395A2 Method of utilizing neurotrophins to manipulate reproductive capacity |
| 02/13/2003 | WO2003011384A1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 02/13/2003 | WO2003011344A1 Novel method and device for treatment of exercise induced pulmonary hemorrhage in horses |
| 02/13/2003 | WO2003011340A1 Medicament formulation for topical application in the therapy and prophylaxis of hyperhidrosis |
| 02/13/2003 | WO2003011339A1 Composition for epigallocatechin gallate |
| 02/13/2003 | WO2003011338A1 Regulation of gastric acid secretion by inwardly rectifying k+ channels |
| 02/13/2003 | WO2003011334A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011311A1 Bauhinia extracts |
| 02/13/2003 | WO2003011310A1 Methods and compositions for control of coccidiosis |
| 02/13/2003 | WO2003011309A2 Pharmaceutical composition for treating hypercholesterolaemia |
| 02/13/2003 | WO2003011308A1 Drugs for ameliorating postcibal hyperglycemia |
| 02/13/2003 | WO2003011307A1 Use of oversulfated polysaccharides as inhibitors of hiv |
| 02/13/2003 | WO2003011305A1 Composition of glycosaminoglycan and a peroxide for the treatment of dry eye |
| 02/13/2003 | WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| 02/13/2003 | WO2003011303A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2003011301A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 02/13/2003 | WO2003011300A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 02/13/2003 | WO2003011299A2 Treatment of ocular hypertension and glaucoma |
| 02/13/2003 | WO2003011296A1 Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient |
| 02/13/2003 | WO2003011295A1 Fexofenadine polymorph |
| 02/13/2003 | WO2003011294A2 Mucin synthesis inhibitors |
| 02/13/2003 | WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011291A1 Transdermal therapeutic system (reservoir-tts) for using pramipexole and ropinirole |
| 02/13/2003 | WO2003011290A1 Methods for inhibiting or reversing tau filament formation polymerization |
| 02/13/2003 | WO2003011289A1 Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines |
| 02/13/2003 | WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 02/13/2003 | WO2003011285A1 BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES |
| 02/13/2003 | WO2003011284A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 02/13/2003 | WO2003011283A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 02/13/2003 | WO2003011282A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/13/2003 | WO2003011281A1 Treatment of attention deficit hyperactivity disorder or attention deficit disorder |
| 02/13/2003 | WO2003011280A1 Use of vitamin e succinate and antiandrogen combination |
| 02/13/2003 | WO2003011279A1 (-)-olivil as antioxidant |
| 02/13/2003 | WO2003011278A1 Crystalline composition containing escitalopram |
| 02/13/2003 | WO2003011277A2 Methods to mobilize progenitor/stem cells |
| 02/13/2003 | WO2003011276A1 Nf?b inhibitor |
| 02/13/2003 | WO2003011275A1 Swine growth promoters and method of promoting swine growth |
| 02/13/2003 | WO2003011274A2 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma |
| 02/13/2003 | WO2003011273A1 Metformin in the treatment of hyperglycemic conditions |
| 02/13/2003 | WO2003011272A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| 02/13/2003 | WO2003011271A2 Methods and compositions for modulating brain damage |
| 02/13/2003 | WO2003011270A1 Agent for treating depressive disorders containing a local anesthetic agent |
| 02/13/2003 | WO2003011269A1 Agent for treating the symptoms of dementia disorders containing an additional local anesthetic agent |
| 02/13/2003 | WO2003011268A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 02/13/2003 | WO2003011267A1 Antiobesity drugs and materials thereof |
| 02/13/2003 | WO2003011266A2 Azalide antibiotic compositions |
| 02/13/2003 | WO2003011265A2 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds |
| 02/13/2003 | WO2003011264A2 Betacarboline derivatives as gaba a-receptor-modulators having nmda-antagonistic activity for treating diseases of the central nervous system |
| 02/13/2003 | WO2003011263A2 Use of a lactate salt for the treatment and prophylaxis of atherosclerosis |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | WO2003011261A1 Cyanoacrylate monomer-containing antibiotic formulation for topical use |
| 02/13/2003 | WO2003011260A1 Method for the continuous production and coating of self-adhesive compounds on the basis of sbc that includes at least one pharmaceutically active substance |
| 02/13/2003 | WO2003011258A1 Pharmaceutical formulations comprising ketoconazole |
| 02/13/2003 | WO2003011256A1 Oral controlled release pharmaceutical composition of a prokinetic agent |
| 02/13/2003 | WO2003011255A1 Gastric retention controlled drug delivery system |
| 02/13/2003 | WO2003011249A2 Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome |
| 02/13/2003 | WO2003011244A1 Composition containing a steroid and a glycol |
| 02/13/2003 | WO2003011243A1 Invert emulsion containing dhea |
| 02/13/2003 | WO2003011242A1 Cosmetic or dermatological preparations containing a combination of creatinine and/or creatinine derivatives and creatine and/or the derivatives thereof |
| 02/13/2003 | WO2003011241A1 Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations |
| 02/13/2003 | WO2003011229A2 Durable multi-component antibiotic formulation for topical use |
| 02/13/2003 | WO2003011227A2 Taste masking composition |
| 02/13/2003 | WO2003011226A2 Products and drug delivery vehicles |
| 02/13/2003 | WO2003011225A2 Calcium glutarate supplement and phosphorus binder |
| 02/13/2003 | WO2003011224A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 02/13/2003 | WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/13/2003 | WO2003011210A2 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2003011207A2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 02/13/2003 | WO2003011178A2 Method for treatment of ocular hypertension and glaucoma |
| 02/13/2003 | WO2003011119A2 Methods and compositions for diagnosis and treatment of vascular conditions |
| 02/13/2003 | WO2003011114A2 Methods for treating prostatitis |
| 02/13/2003 | WO2003011054A1 Complex antioxidant preparation |
| 02/13/2003 | WO2003011042A1 Soluble roasted chicory with high inulin content |
| 02/13/2003 | WO2003011008A2 Therapeutic delivery compositions and methods of use thereof |
| 02/13/2003 | WO2003004016A8 Use of substituted gamma-lactone compounds as medicaments |
| 02/13/2003 | WO2002096855A3 Anticholinergic compounds and methods of use |
| 02/13/2003 | WO2002094275A8 Use of estrogen compounds to increase libido in women |
| 02/13/2003 | WO2002092062A3 Combination of vitamin d analogue and pyrimidine nucleoside analogue |
| 02/13/2003 | WO2002090363A8 ANHYDROUS CRYSTAL OF ss-LACTAM COMPOUND AND METHOD FOR PREPARATION THEREOF |
| 02/13/2003 | WO2002089730A3 Compounds and methods for the modulation of cd154 |
| 02/13/2003 | WO2002088146A3 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE |
| 02/13/2003 | WO2002087574A3 Use of pyridoindolone derivatives for preparing anticancer medicines |
| 02/13/2003 | WO2002087546A3 Method for manufacturing a low dose pharmaceutical composition |
| 02/13/2003 | WO2002083657A3 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 02/13/2003 | WO2002083079A3 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 02/13/2003 | WO2002081028A3 Cytoprotection by phosphotyrosine |
| 02/13/2003 | WO2002078638A3 Morpholino imaging and therapy |
| 02/13/2003 | WO2002077007A3 Novel polyaminated fusidic acid derivatives |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002074231A3 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata |
| 02/13/2003 | WO2002072035A3 Novel anti-inflammatory compositions and methods of use |
| 02/13/2003 | WO2002069925A3 Use of $g(a)-lipoic acid in cosmetic or dermatological preparations |
| 02/13/2003 | WO2002062810A3 Linkable sialyl lewis x analogs |
| 02/13/2003 | WO2002060482A3 Perylenequinones for use with immunotherapy agents |